ClinicalTrials.govpublic full text
L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
end-stage renal disease, peritoneal dialysis, l-carnitine, esrd, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 887822
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.